🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

3 recruiting trials

for Retinal Vein Occlusion With Macular Edema

Mecobalamin Combined With Anti-VEGF Intravitreal Injection for Retinal Vein Occlusion Treatment NCT07133438Phase 41 site📍 Chongqing First Affiliated Hospital of Chongqing Medical University · Tests: Anti-VEGF drug, Mecobalamin 5 MG, Placebo Efficacy and Safety Evaluation of SMO1 in Patients With Retinal Vein Occlusive Macular Edema NCT07708142Phase 31 site📍 Seoul SANGMYUNG innovation · Tests: Reference Drug, SMO1 A Dose-masked Study of Intravitreal Remigromig (EYE103) in Participants With NVAMD or Macular Edema Following BRVO NCT07205887Phase 255 sites📍 Scottsdale📍 Scottsdale📍 Glendale EyeBiotech Ltd. · Tests: Remigromig, Aflibercept 2.0 mg
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy